Park County COVID19 Vaccine Resources
The clinics have Moderna, Pfizer and Johnson & Johnson vaccines available for first, second, third and booster doses for eligible populations.
New! All clinics will offer the Omicron-variant booster doses. For more information, please review the CDC Authorization.
- 9/11/22 from 12 - 5 PM Park County Government Building, 59961 US Hwy 285, Bailey CO 80421. Register here.
- 9/28/22 from 12 - 5 PM NorthWest Fire District Station, 21455 US Hwy 285 Fairplay, CO 80440. Register here.
- 10/09/22 from 12 - 5 PM Park County Government Building, 59961 US Hwy 285, Bailey CO 80421 Register here.
- 10/12/22 from 12 - 5 PM NorthWest Fire District Station, 21455 US Hwy 285 Fairplay, CO 80440 Register here.
- 10/23/22 from 12 - 5 PM Park County Government Building, 59961 US Hwy 285, Bailey CO 80421 Register here.
- 10/26/22 from 12 - 5 PM NorthWest Fire District Station, 21455 US Hwy 285 Fairplay, CO 80440 Register here.
Appointments and walk-ins accepted!
CDC Approves Updated Pfizer and Moderna Omicron Booster
On Sept. 1, the Centers for Disease Control and Prevention (CDC) officially approved Pfizer and Moderna’s updated COVID-19 omicron doses designed to offer protection from the original COVID-19 virus and the omicron variant of the COVID-19 virus. The Food and Drug Administration authorized both vaccines under an Emergency Use Authorization on Wednesday, August 31. Pfizer’s omicron dose is authorized for people aged 12 years and older. Moderna’s omicron dose is authorized for people aged 18 years and older.
Anyone aged 12 years and older who has completed a primary series of COVID-19 vaccines should receive an omicron dose. A primary series usually means two doses of Pfizer, Moderna, or Novavax, or one dose of Johnson & Johnson. People who are immunocompromised may receive up to three doses in their primary series. Additionally, anyone who has previously received a third, fourth, or fifth dose — also known as booster doses — should receive an omicron dose. People should get their omicron dose at least two months after their most recent dose of the COVID-19 vaccine and can wait three months after a recent COVID-19 infection.
Learn more about omicron vaccine doses at www.covid19.colorado.gov/vaccine.
CDC Recommends Children 6 months and Older be Vaccinated
On June 18, 2022, the CDC recommended children 6 months - 5 years be vaccinated against COVID-19. Parents and caregivers can now get their children 6 months through 5 years of age vaccinated with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. All children, including children who have already had COVID-19, should get vaccinated, according to the CDC.
For more information about the COVID-19 vaccine, including clinic locations near you, including Park County sites, please visit: https://covid19.colorado.gov/kids-vaccines.
Questions? Please contact your child’s primary care provider.
On Nov. 2, the Centers for Disease Control and Prevention (CDC) gave a final approval for use of the Pfizer COVID-19 vaccine for 5-11 year-olds.
Many of the current vaccine sites will carry the pediatric Pfizer vaccines, please check availability when registering for an appointment. If you have questions, please speak with your child's pediatrician. Also visit the CDC's COVID vaccine website for children and teens.
Electronic Proof of COVID19 Vaccine
Do you need proof of your COVID-19 vaccine? You can visit the the state's website and save an electronic version of the same format as the paper CDC card the user received when they were vaccinated. myColorado app users can download a copy to their device, refresh or delete the record.
Safety and Monitoring:
- On July 13, the FDA published a press release and sent a fact sheet and another fact sheet to healthcare providers (i.e.doctors, nurses, hospitals, etc.) about a recent safety signal they detected: Guillain-Barre Syndrome (GBS). Based on an analysis of Vaccine Adverse Event Reporting (VAERS) data, the FDA found 100 reports of GBS following 12.5 million vaccines. Out of the 100 cases, 95% were serious and required hospitalization. One person died.
- On June 23, CDC issued a safety concern associated with Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination
- On April 23, the press release from the FDA and CDC, who determined the use of the Janssen COVID-19 Vaccine should be resumed in the United States and that the FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19. CDPHE has decided to proceed by including FDA’s updated warning to patients about the increased risk of very rare but potentially severe TTS, particularly among women under the age of 50.
- On August 23, the FDA granted full approval to the Pfizer COVID19 vaccine for ages 16 and older, marking an important milestone in the ongoing pandemic.
- On August 11, the CDC released additional safety data related to pregnant people receiving the COVID19 vaccine, more details can be found here: https://www.cdc.gov/media/releases/2021/s0811-vaccine-safe-pregnant.html
- The Johnson & Johnson and Moderna vaccines are authorized for ages 18 and older and the Pfizer vaccine is approved for 12 and older. Please check the clinic you are registering for carefully to ensure it is offering your preferred choice.
- On May 10, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer COVID-19 Vaccine for the prevention of COVID-19 to include adolescents 12 through 15 years of age. The FDA previously amended the EUA for administration in individuals 16 years of age and older. All ages are subject to change.
- Vaccine Finder: allows you to search by vaccine type and location in Colorado.
- Overview of approved vaccines
Who Shouldn't Get a Vaccine?
The vaccines have received Emergency Use Authorization (EUA) by the FDA and are considered highly safe and effective at preventing COVID-19 infections. Most people 12 years and older (for Pfizer) and 18 and older (for Moderna and Johnson and Johnson vaccines) are able to safely receive the vaccine, but please contact your doctor if you:
- Are currently in isolation or have a fever 24 hours after the end of isolation with no improvement in symptoms
- Had a severe allergic reaction after a previous dose of this vaccine
- Have had a severe allergic reaction to any ingredient of this vaccine.
A Compilation of Vaccine Resources and Information
The development and distribution a COVID-19 vaccine will require a large scale effort by state, local, and private sector partners. The first phase will focus on frontline health care workers, first responders, and our most vulnerable populations living in long-term care facilities. Until the vaccine is widely available to the general public, we all need to continue to follow critical public health protocols. Please wear a mask in public, maintain at least 6 feet of distance from others, avoid gatherings, wash your hands often, and stay home when you are sick.
Scientists have developed several possible vaccines to provide immunity to COVID-19. Once a company develops a vaccine, it must go through a rigorous scientific testing process before it can be submitted to the Food and Drug Administration (FDA). The FDA independently reviews the information from these tests to make sure the vaccine is safe and works well, and then decides whether the vaccine can be licensed and made available to the public. The pharmaceutical companies Pfizer and Moderna have applied for an Emergency Use Authorization with the Food and Drug Administration (FDA). The FDA authorized the Pfizer vaccine for emergency use on December 11, and Colorado received the vaccine beginning December 14. Moderna vaccine is expected to arrive in Colorado the week of December 22.
Safety and Effectiveness:
The companies report that both vaccines are around 95% effective. While the development process was efficient, the world's leading vaccine companies, in conjunction with the FDA and independent scientists, have used the same rigorous structure to develop these vaccines as has been used for all other drug and vaccine development. These involve multiple studies or “phased trials” across many months with larger and larger groups of people to ensure that the vaccine is both safe and effective for the general public. Tens of thousands of individuals across the US and the world have volunteered and helped provide this important information.
About mRNA-1273, Moderna’s Vaccine Against COVID-19:
The Moderna vaccine, or mRNA-1273 works by helping the immune system produce effective antibodies against the SARS-CoV-2 virus so that, in case of infection, the virus does not cause illness. The vaccine cannot cause infection or make someone sick with COVID-19. Learn more about the Moderna vaccine safety and effectiveness by the FDA here.
Both mRNA vaccines require two injections, given either 21 or 28 days apart. The first dose primes the immune system and the second dose helps boost the immune system even further to help provide better protection against the coronavirus. Two shots spaced apart are necessary as the Pfizer vaccine has been shown to be 95% effective after an individual receives 2 doses, however, only 52% effective if an individual receives just a single dose.
Other Trusted Resources
- What to expect at your vaccination appointment
- What to expect after getting vaccinated
- Post-vaccination considerations for healthcare personnel
- Post-vaccination considerations for long-term care residents
- CDC vaccine